Skip to content

Medical-device intelligence

JTN: Susceptibility Test Discs, Antimicrobial

FDA product code JTN: Susceptibility Test Discs, Antimicrobial. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
JTN
FDA device name
Susceptibility Test Discs, Antimicrobial
Device class
2
Regulation number
866.1620
Medical specialty
Microbiology
Review panel
MI

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

331 clearance records and 47 recall records in the covered releases, across 30 source company names and 1 product codes. Dated history runs from Nov 16, 1976 to Aug 20, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202510
December 202510
January 202600
February 202600
March 202600
April 202600
May 202610
June 202601
July 202620
August 202610
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
JTN · Susceptibility Test Discs, Antimicrobial33147

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

378 matching records
Device / recordCompany in FDA recordSourceSource date
BD BBL Sensi Disc Cefotaxime - 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231606 and 231607; 5 ug, Catalog…Z-1020-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Cefpodoxime - 10 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231673 and 231674Z-1021-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Ceftaroline - 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 232231Z-1022-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Ceftazidime- 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231632and 231633Z-1023-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Ceftriaxone- 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231634 and 231635Z-1024-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Cefuroxime- 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231621Z-1025-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Chloramphenicol- 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 230733and 231274Z-1026-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Ciprofloxacin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231657and 231658Z-1027-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Clarithromycin- 15 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231678Z-1028-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Doripenem- 15 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 232219Z-1029-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Ertapenem- 10 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 232174 and 232175Z-1030-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Imipenem- 10 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231644 and 231645Z-1031-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Levofloxacin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231705 and 231706Z-1032-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Meropenem- 10 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231703 and 231704Z-1033-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Minocycline - 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231250 and 231251Z-1034-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Moxifloxacin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231758Z-1035-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Ofloxacin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231672Z-1036-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Piperacillin/Tazobactam- 100/10 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231691 and 2316…Z-1037-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Rifampin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231541 and 231544Z-1038-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Sulfamethoxazole with Trimethoprim 23.75/1.25 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 23…Z-1039-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Tetracycline 30 ug,used for semi-quantitative in vitro susceptibility testing. Catalog Number 230998 and 231344Z-1040-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
Thermo Scientific Oxoid Sulbactam/Durlobactam Disc (10/10 µg) SUD20K232276 · JTNOxoid Limited (Part of Thermo Fisher Scientific)510(k)Oct 6, 2023FDA decision date
HardyDisk AST Sulbactam/Durlobactam 10/10µg (SUD20)K231568 · JTNHardy Diagnostics510(k)Jul 6, 2023FDA decision date
BD BBL™ Sensi-Disc™ Lefamulin 20µg (LMU-20)K230651 · JTNBecton, Dickinson and Company510(k)Jun 7, 2023FDA decision date
HardyDisk AST Rezafungin 5µg (RZF5)K230827 · JTNHardy Diagnostics510(k)Jun 1, 2023FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗